COLL — COLLEGIUM PHARMACEUTICAL, INC
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1267565 ·
Last close
$25.55
Market Cap
$793.98M
52W High
$50.79
52W Low
$21.43
ADV30
640,177
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 216,339,000 | 125,418,000 | 25,827,000 | 21,759,000 | 2,095,936,000 | 144,797,000 | 1,799,500,000 |
| Jun 2026 | 199,878,000 | 110,292,000 | 3,698,000 | -15,051,000 | 2,135,790,000 | 129,467,000 | 1,823,881,000 |
| Mar 2026 | 193,520,000 | 117,246,000 | 30,896,000 | 14,496,000 | 1,651,955,000 | 268,648,000 | 1,339,533,000 |
| Dec 2025 | 205,449,000 | 128,378,000 | 60,738,000 | 16,963,000 | 1,656,834,000 | 231,252,000 | 1,355,159,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$338,020,000
Investing CF
$-521,310,000
Financing CF
$177,999,000
CapEx
$-1,732,000
Dividends Paid
—
Buybacks
$-50,000,000
EPS Diluted TTM
$1.00
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-79,925,000
Inventory
$88,202,000
Receivables
$310,785,000
ST Investments
$0
EBIT TTM
$118,766,000
Pretax Income TTM
$42,150,000
Interest Exp TTM
$76,616,000
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$815,185,984
EBITDA
$419,617,984
Free Cash Flow
$366,986,496
Enterprise Value
$1,815,156,992
Total Cash
$144,796,992
Total Debt
$1,207,618,048
Shares Out
31,075,424
Trailing EPS
$1.09
Book Value
$9.54
ROE
13.4%
ROA
6.3%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 780,567,000 | 178,454,000 | 62,870,000 | 1,656,834,000 | 1,355,159,000 | 301,675,000 | 329,323,000 |
| Dec 2024 | 631,449,000 | 166,981,000 | 69,190,000 | 1,663,591,000 | 1,434,749,000 | 228,842,000 | 204,980,000 |
| Dec 2023 | 566,767,000 | 166,961,000 | 48,155,000 | 1,143,308,000 | 947,877,000 | 195,431,000 | 274,749,000 |
| Dec 2022 | 463,933,000 | 33,319,000 | -25,002,000 | 1,174,131,000 | 979,289,000 | 194,842,000 | 124,230,000 |
TTM Snapshot
Revenues TTM
$808,208,000
NetIncome TTM
$47,915,000
OpCashFlow TTM
—
Assets (Latest)
$2,135,790,000
Forward EPS
$7.26
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $45.00 · spot: $25.93 · call volume: 24 · put volume: 418
Expected Move to 2026-12-18:
±$2.80
(10.80%) —
implied range
$23.13 –
$28.73
· ATM straddle on $25.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | $792.52M | $1.78 | — |
| ARDX | ARDELYX, INC. | $799.36M | $3.18 | — |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $806.23M | $4.87 | — |
| RIGL | RIGEL PHARMACEUTICALS INC | $808.18M | $42.92 | — |
| SNDX | Syndax Pharmaceuticals Inc | $828.26M | $9.20 | — |
News headlines (Yahoo Finance, 1h cache)
Wall Street Analysts Believe Collegium Pharmaceutical (COLL) Could Rally 81.63%: Here's is How to Trade
2026-11-10 13:55 · Yahoo
COLL Q3 2026 deep dive: ADHD portfolio drives growth as pain business stabilizes
2026-11-10 10:37 · Yahoo
Collegium Pharmaceutical (COLL) Stock Gets Fair Value Trim As Analysts Weigh Pain And ADHD
2026-11-10 07:10 · Yahoo
Collegium Pharmaceutical Inc (COLL) (Q3 2026) Earnings Call Highlights: ADHD Franchise Hits ...
2026-11-06 21:09 · Yahoo
Collegium Pharmaceutical, Inc. Q3 2026 Earnings Call Summary
2026-11-05 23:28 · Yahoo
Collegium (COLL) Q3 2026 Earnings Call Transcript
2026-11-05 20:13 · Yahoo
Collegium Pharmaceutical Q3 Earnings Call Highlights
2026-11-05 15:14 · Yahoo
Collegium Pharmaceutical (COLL) Tops Q3 Earnings and Revenue Estimates
2026-11-05 13:35 · Yahoo
Collegium Pharmaceutical (NASDAQ:COLL) posts in line Q3 2026 sales and full year revenue guidance above estimates, stock soars
2026-11-05 13:33 · Yahoo
J&J to Boost Ophthalmology Pipeline With $2.2B Ollin Acquisition
2026-11-17 14:21 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.